<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01571518</url>
  </required_header>
  <id_info>
    <org_study_id>2011-91</org_study_id>
    <nct_id>NCT01571518</nct_id>
  </id_info>
  <brief_title>Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy</brief_title>
  <official_title>Optimal Timing and Duration of Daily G-CSF With Adjuvant TAC Chemotherapy in Node-positive Breast Cancer;Multicenter, Randomized, Open Label, Clinically IV Phase</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hyuk moon Kim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dong-A Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Sunchonhang University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After resection of lymph node positive breast cancer, the injection duration and timing of
      Granulocyte-colony stimulating factor (G-CSF) could affect the neutropenia with TAC
      (Taxotere, Adriamycin, cyclophosphamide) chemotherapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The duration and the injection timing of G-CSF are effective in the prevention of
      neutropenia, incidence of infection and non hematologic toxicity. With the TAC chemotherapy
      after resection of breast cancer, the G-CSF early injection versus late injection could
      change the frequency of neutropenia.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>frequency of neutropenia</measure>
    <time_frame>Change from Baseline in neutrophil count at 21days</time_frame>
    <description>during the 1 cycle (21days) of ajuvant chemotherapy with TAC, record the frequency of neutropenia aftr using G-CSF (Leucostim)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Neutropenia</condition>
  <arm_group>
    <arm_group_label>early injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injection of G-CSF (leukostim)5㎍/kg from day 2 of TAC chemotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>late injection</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>injection of G-CSF (leukostim)5㎍/kg from day 5 of TAC chemotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>late leukostim</intervention_name>
    <description>injection of G-CSF (leukostim)5㎍/kg from day 5 of TAC chemotherapy</description>
    <arm_group_label>early injection</arm_group_label>
    <other_name>5leuko</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>early leukostim</intervention_name>
    <description>injection of G-CSF (leukostim)5㎍/kg from day 2 of TAC chemotherapy</description>
    <arm_group_label>late injection</arm_group_label>
    <other_name>2leuko</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  primary invasive breast carcinoma with lymph node positive with curative surgery with
             TAC chemotherapy

        Exclusion Criteria:

          -  pregnancy,

          -  cardiovascualr disease,

          -  abnormal renal function,

          -  hematologic disorder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chul Wan Lim, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Soonchunhyang U Puchun Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chul Wan Lim, M.D., Ph.D</last_name>
    <phone>82-32-621-5114</phone>
    <email>cylim@soonchunhyang.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Soonchunhyang university Puchun Hospital</name>
      <address>
        <city>Puchun</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hyuk moon Kim, MD</last_name>
      <phone>82-32-621-5114</phone>
      <email>hmkim@soonchunhyang.com</email>
    </contact>
    <investigator>
      <last_name>ChulWan Lim, MD.PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Chan A, Fu WH, Shih V, Coyuco JC, Tan SH, Ng R. Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy. Support Care Cancer. 2011 Apr;19(4):497-504. doi: 10.1007/s00520-010-0843-8. Epub 2010 Mar 17.</citation>
    <PMID>20232087</PMID>
  </results_reference>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2012</study_first_submitted>
  <study_first_submitted_qc>April 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2012</study_first_posted>
  <last_update_submitted>April 3, 2012</last_update_submitted>
  <last_update_submitted_qc>April 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sunchonhang University</investigator_affiliation>
    <investigator_full_name>Hyuk moon Kim</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>G-CSF</keyword>
  <keyword>neutropenia</keyword>
  <keyword>TAC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neutropenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lenograstim</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

